Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05135169 · ClinicalTrials.gov registry record

Multi-organ Transit Time Acquisition Using Contrast Ultrasound

A clinical trial of Healthy, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
16
Enrollment target
1
Study location

NCT05135169 is a study of Healthy that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 16 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05135169, a study of Healthy, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
16 participants
Enrollment target
1
Study location

Study Summary

Echocardiographic contrast will be administered to volunteers for the purpose of measuring transit time through various organs/vascular beds

Conditions Studied

Interventions

  • DRUG Definity Suspension for Injection

Study Locations (1)

Tennessee

  • VUMC - Nashville

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2022-03-03
Est. Completion 2025-06-30

What the Registry Record Tells You About NCT05135169

The ClinicalTrials.gov registry entry for NCT05135169 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Definity Suspension for Injection is the first listed.

NCT05135169 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT05135169 about?

NCT05135169 is a clinical study titled "Multi-organ Transit Time Acquisition Using Contrast Ultrasound". Echocardiographic contrast will be administered to volunteers for the purpose of measuring transit time through various organs/vascular beds

What is the current status of trial NCT05135169?

This trial is currently completed. The enrollment target is 16 participants. The study started on 2022-03-03. Estimated completion is 2025-06-30.

What conditions does trial NCT05135169 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT05135169?

The interventions under investigation include: Definity Suspension for Injection (DRUG).

Who is sponsoring clinical trial NCT05135169?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05135169 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.